Clinical Trial Update: A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial update indicates that Taiho Oncology’s Phase 1 dose-finding study followed by a safety and efficacy study in patients with multiple myeloma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Multiple Myeloma, NonHodgkin Lymphoma | Phase 1 | Status: TERMINATED